Express Pharma

Glenmark receives ANDA approval for Olmesartan Medoxomil tabs

0

The tablets will be manufactured at its Goa facility

Glenmark Pharmaceuticals has been granted final approval by the US FDA for Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg. It is the generic version of Benicar Tablets, 5 mg, 20 mg and 40 mg, of Daiichi Sankyo. Glenmark’s Olmesartan Medoxomil tablets will be manufactured by Glenmark Pharmaceuticals in its manufacturing facility located in Goa.

 

Comments are closed.